Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Immunocore Holdings plc (IMCR) Balance Sheet

As of 2026-06-30 (10-Q), Immunocore Holdings plc (IMCR) reported total assets of $1.1B, total liabilities of $699.6M and shareholders' equity of $419.8M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $484.9M.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

IMCRImmunocore Holdings plcFollow IMCR — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
1.6B
P/E TTM
—
Dividend yield
0.0%
52-week
—
Next earnings
4 Nov, in 11 days
LineFY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
Latest
Jun 26
Trend
Cash and equivalents0.400.440.460.470.48
Short-term investments—0.000.360.400.40
Receivables0.030.050.06——
Inventory0.000.000.010.010.01
Current assets0.470.530.931.001.05
Total assets0.530.601.011.071.12
Current liabilities0.100.140.210.250.24
Total liabilities0.190.230.650.690.70
Shareholders' equity0.340.370.360.380.42

USD billions · SEC XBRL

Immunocore Holdings plc — questions

How much cash does Immunocore Holdings plc have?
$484.9M in cash and cash equivalents as of 2026-06-30.
What are Immunocore Holdings plc's total assets?
$1.1B as of 2026-06-30.
What is Immunocore Holdings plc's shareholders' equity?
$419.8M as of 2026-06-30.

Every figure on this page comes from Immunocore Holdings plc's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.